Back to Journals » Drug Design, Development and Therapy » Volume 7

Review

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin

         
Total article views   Abstract views HTML views PDF downloads Totals
16,321 Dovepress* 9,264 575+ 2,800 9,839
PubMed Central* 5 6,477 2,589 6,482
Totals 9,269 7,052 5,389 16,321
*Since 17 September 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 2 7

View citations on PubMed Central and Google Scholar